Roumiana Markova

1.2k total citations · 1 hit paper
18 papers, 606 citations indexed

About

Roumiana Markova is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Roumiana Markova has authored 18 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Roumiana Markova's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pediatric health and respiratory diseases (5 papers). Roumiana Markova is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pediatric health and respiratory diseases (5 papers). Roumiana Markova collaborates with scholars based in Bulgaria, Italy and United Kingdom. Roumiana Markova's co-authors include Daniela María Cirillo, Davide Manissero, Morten Rühwald, Christoph Lange, Albert Nienhaus, Roland Diel, Beate Kampmann, Dirk Wagner, Jean-Pierre Zellweger and Monica Losi and has published in prestigious journals such as European Respiratory Journal, International Immunopharmacology and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Roumiana Markova

18 papers receiving 589 citations

Hit Papers

Interferon-γ release assays for the diagnosis of latentMy... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roumiana Markova Bulgaria 9 487 418 319 89 41 18 606
Luiz Claudio Oliveira Lazzarini Brazil 13 593 1.2× 535 1.3× 328 1.0× 136 1.5× 76 1.9× 14 747
Sophia Siddiqui United States 10 403 0.8× 336 0.8× 128 0.4× 99 1.1× 66 1.6× 21 516
E Brander Finland 13 316 0.6× 408 1.0× 145 0.5× 175 2.0× 70 1.7× 30 685
N.G. Fomukong United States 12 396 0.8× 319 0.8× 153 0.5× 80 0.9× 62 1.5× 13 474
Virginie Verscheure Belgium 13 306 0.6× 468 1.1× 98 0.3× 210 2.4× 58 1.4× 17 648
Yukie Sekiya Japan 12 345 0.7× 296 0.7× 292 0.9× 89 1.0× 25 0.6× 18 479
Patrick K. Owiafe Gambia 13 635 1.3× 528 1.3× 221 0.7× 285 3.2× 104 2.5× 25 810
Amanda McBride United States 8 268 0.6× 216 0.5× 97 0.3× 201 2.3× 78 1.9× 10 560
Eliahou Bishburg United States 7 326 0.7× 405 1.0× 132 0.4× 33 0.4× 14 0.3× 8 562
Jesse M. Hofflin United States 10 123 0.3× 424 1.0× 137 0.4× 56 0.6× 32 0.8× 10 634

Countries citing papers authored by Roumiana Markova

Since Specialization
Citations

This map shows the geographic impact of Roumiana Markova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roumiana Markova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roumiana Markova more than expected).

Fields of papers citing papers by Roumiana Markova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roumiana Markova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roumiana Markova. The network helps show where Roumiana Markova may publish in the future.

Co-authorship network of co-authors of Roumiana Markova

This figure shows the co-authorship network connecting the top 25 collaborators of Roumiana Markova. A scholar is included among the top collaborators of Roumiana Markova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roumiana Markova. Roumiana Markova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nikolova, Maria, et al.. (2013). Peripheral Blood CD8 T Cell Response in Different Phases of MTB Infection. Proceedings of the Bulgarian Academy of Sciences. 66(4). 2 indexed citations
2.
Nikolova, Maria, et al.. (2012). Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagnostic Microbiology and Infectious Disease. 75(3). 277–281. 63 indexed citations
3.
Markova, Roumiana, et al.. (2011). Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis.. PubMed. 34(1). 81–5. 12 indexed citations
4.
Diel, Roland, Delia Goletti, Giovanni Ferrara, et al.. (2010). Interferon-γ release assays for the diagnosis of latentMycobacterium tuberculosisinfection: a systematic review and meta-analysis. European Respiratory Journal. 37(1). 88–99. 403 indexed citations breakdown →
5.
Amicosante, Massimo, Massimo Ciccozzi, & Roumiana Markova. (2010). Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies.. PubMed. 33(2). 93–107. 13 indexed citations
6.
Seghrouchni, Fouad, Roumiana Markova, Khalid Sadki, et al.. (2009). Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. Tuberculosis. 89(3). 210–217. 8 indexed citations
7.
Markova, Roumiana, et al.. (2009). Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. International Immunopharmacology. 9(7-8). 831–836. 8 indexed citations
8.
Markova, Roumiana, et al.. (2009). Usefulness of Interferon-Gamma Release Assays in the Diagnosis of Tuberculosis Infection in HIV-Infected Patients in Bulgaria. Biotechnology & Biotechnological Equipment. 23(1). 1103–1108. 16 indexed citations
9.
Markova, Roumiana, et al.. (2008). Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test. European Respiratory Review. 17(108). 74–75. 3 indexed citations
10.
Markova, Roumiana, et al.. (2007). Genetic Polymorphism of the Chemokine Co-Receptors CCR5, CXCR4 and CCR2 in Bulgarians Living with HIV. Biotechnology & Biotechnological Equipment. 21(3). 328–334. 3 indexed citations
11.
Petrunov, Bogdan, et al.. (2006). Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator “Dentavax”. International Immunopharmacology. 6(7). 1181–1193. 22 indexed citations
12.
Markova, Roumiana, et al.. (2005). Cellular and Humoral Systemic and Mucosal Immune Responses Stimulated by an Oral Polybacterial Immunomodulator in Patients with Chronic Urinary Tract Infections. International Journal of Immunopathology and Pharmacology. 18(3). 457–473. 32 indexed citations
13.
Petrunov, Bogdan, et al.. (2000). Immunostimulating and protective effects of an oral polybacterial immunomodulator ‘Dentavax’ in a rabbit experimental model. International Journal of Immunopharmacology. 22(11). 843–854. 6 indexed citations
14.
Markova, Roumiana, et al.. (1997). Stimulating effect of an oral polybacterial immunomodulator on the proliferative activity of guinea pig lymphocytes. International Journal of Immunopharmacology. 19(4). 205–214. 4 indexed citations
15.
Mitov, Ivan, et al.. (1995). Experimental investigations on the immunomodulating activity of polybacterial preparation for peroral immunotherapy and immunoprophylaxis of uroinfections. International Journal of Immunopharmacology. 17(6). 489–496. 5 indexed citations
16.
Markova, Roumiana, et al.. (1982). In vitro cell-mediated immune reactivity in colon cancer patients.. PubMed. 29(5). 567–72. 1 indexed citations
17.
Markova, Roumiana, et al.. (1980). Some parameters of cell-mediated immunity in colon cancer patients.. PubMed. 27(1). 43–6. 1 indexed citations
18.
Markova, Roumiana, et al.. (1978). Delayed hypersensitivity reactions in patients with breast cancer.. PubMed. 25(6). 733–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026